ResQ Medical

Company Overview

Snapshot

Founded in August 2022 by Itamar Dach, Amnon Weichselbaum, and Ali Mafra, ResQ Medical operates with 1–10 employees. The company has raised $800,000 across three funding rounds from one investor. ResQ Medical is developing ALMA, an innovative device for treating Postpartum Hemorrhage (PPH).

Business overview

ResQ Medical is a Health Tech & Life Sciences company focused on developing a safe and effective device for treating Postpartum Hemorrhage (PPH). The company's core product, ALMA, aims to support the natural contraction of the uterus to stop bleeding, offering an alternative to current medical devices that rely on balloon inflation. ResQ Medical serves the healthcare industry, specifically targeting providers in gynecology and women's health, with a focus on medical devices and therapeutics.

Company Intelligence Q&A

What is ResQ Medical's primary focus?

ResQ Medical is dedicated to developing a cutting-edge device for treating Postpartum Hemorrhage (PPH), aiming to make it an essential tool in delivery rooms and the first choice for PPH treatment.

When was ResQ Medical founded?

ResQ Medical was founded in August 2022.

What is the name of ResQ Medical's flagship product?

ResQ Medical is developing ALMA, a device designed to support the natural contraction of the uterus to stop bleeding in cases of Postpartum Hemorrhage (PPH).

How much capital has ResQ Medical raised?

ResQ Medical has raised $800,000 across three funding rounds.

Which investor participated in ResQ Medical's funding?

In August 2022, ResQ Medical received funding from Youdim Pharmaceuticals, which also incubated the company.